First Postoperative Day Review After Uneventful Phacoemulsification

Complications Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01247155
• Other study ID #: 9151
• Status: Completed
• Phase: N/A
• First received: November 23, 2010
• Last updated: November 23, 2010

Study information

• Verified date: April 2009
• Source: Veroia General Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Greece: Ethics Committee
• Study type: Observational

Clinical Trial Summary

The purpose of this randomized trial was to examine the value of the review on the first postoperative day after uneventful phacoemulsification cataract surgery.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Gender: Both
• Age group: 65 Years to 90 Years

Eligibility

Inclusion Criteria:

Exclusion Criteria:

Exclusion criteria were the following:

i) intra-operative complications, such as posterior capsule rupture, vitreous loss, lost nucleus, zonule dehiscence and wound leak,

ii) inadequate social support for overnight care at home,

iii) severely limited visual potential in the fellow eye,

iv) uveitis or ocular trauma,

v) severe systemic diseases limiting activity,

vi) patients with learning disability or dementia.

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• BCVA
• Complications
• Phacoemulsification

Locations

Country	Name	City	State
Greece	General Hospital of Veroia	Veroia	Imathia

Sponsors (1)

Lead Sponsor	Collaborator
Veroia General Hospital

Country where clinical trial is conducted

Greece, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Best corrected visual acuity